San Diego, September 25, 2014 – GenomeDx Biosciences today announced that it has entered into a contractual agreement with MultiPlan, Inc. for diagnostic laboratory testing. The agreement includes GenomeDx Biosciences’ participation in the MultiPlan Network, expanding access to the Decipher® Prostate Cancer Classifier to health plan members who access the more than 500,000 providers participating […]
Category: Press Releases
GenomeDx Biosciences Launches Decipher Biopsy Test
New Predictor of Prostate Cancer Disease Progression Now Available for Newly Diagnosed Patients San Diego – March 8, 2016 – GenomeDx Biosciences today announced the launch of Decipher Biopsy, a genomic test that evaluates RNA expression-based biomarkers to predict the risk of high-grade disease, metastasis and cancer-specific death at the time of biopsy in men […]
GenomeDx Biosciences to Present at 2015 Wedbush PacGrow Healthcare Conference
San Diego, August 5, 2015 — GenomeDx Biosciences announced that it will present at the Wedbush PacGrow Healthcare Conference at 9:45 a.m. ET on Wednesday, August 12, in New York. Dave Matthews, CFO of GenomeDx, will provide an update about the company’s Decipher® test and an overview of the Company’s pipeline. About Decipher® The Decipher® […]